Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis [0.03%]
PCSK9的遗传和体外抑制与钙化性主动脉瓣狭窄的关系
Nicolas Perrot,Vincenza Valerio,Donato Moschetta et al.
Nicolas Perrot et al.
The authors investigated whether PCSK9 inhibition could represent a therapeutic strategy in calcific aortic valve stenosis (CAVS). A meta-analysis of 10 studies was performed to determine the impact of the PCSK9 R46L variant on CAVS, and th...
Warped Speed: How COVID-19 Transfected and Transformed Medical Journals [0.03%]
扭曲的速度：COVID-19如何影响并改变医学期刊
Douglas L Mann
Douglas L Mann
In Situ Immune Profiling Identifies Immune Players Involved in Allograft Rejection: A Call for Precision Medicine [0.03%]
原位免疫分析确定了参与异体移植排斥的免疫成分：精准医学势在必行
Claudio Napoli,Francesco Donatelli,Ciro Maiello
Claudio Napoli
Cardiac BIN1 Replacement Therapy Ameliorates Inotropy and Lusitropy in Heart Failure by Regulating Calcium Handling [0.03%]
BIN1心脏替代疗法通过调节钙离子处理改善心力衰竭患者的心肌收缩和舒张功能
Jessica Gambardella,Xu Jun Wang,John Ferrara et al.
Jessica Gambardella et al.
Michael D Shapiro,Sergio Fazio
Michael D Shapiro
Scaffold Resorption Process Is Not the Achilles' Heel of the Absorb BVS: But What Then? [0.03%]
可吸收生物工程血管支架的载体材料降解过程并非其短板：那真正的弱点在哪里？
Laura S M Kerkmeijer,Joanna J Wykrzykowska
Laura S M Kerkmeijer
Peter Libby,Amélie Vromman
Peter Libby
Jessica A Hennessey,Steven O Marx
Jessica A Hennessey
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review [0.03%]
钠葡萄糖协同转运蛋白2(SGLT2)抑制剂心血管获益机制的研究进展
Gary D Lopaschuk,Subodh Verma
Gary D Lopaschuk
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have dramatic beneficial cardiovascular outcomes. These include a reduced incidence of cardiovascular death and heart failure hospitalization in people ...
Impact of Coronary Atherosclerosis on Bioresorbable Vascular Scaffold Resorption and Vessel Wall Integration [0.03%]
冠脉粥样硬化对生物可吸收支架降解及血管壁影响的研究
Yanping Cheng,Marco Ferrone,Qing Wang et al.
Yanping Cheng et al.
The integration of the Absorb bioresorbable vascular scaffold (BVS) into the arterial wall has never been tested in an in vivo model of atherosclerosis. This study aimed to compare the long-term (up to 4 years) vascular healing responses of...